Option Care Health, Inc. (NASDAQ:OPCH) Q2 2023 Earnings Conference Call July 27, 2023 8:30 AM ET
Company Participants
Mike Shapiro – Chief Financial Officer
John Rademacher – Chief Executive Officer
Conference Call Participants
Lisa Gill – JPMorgan
Brian Tanquilut – Jefferies
Matt Larew – William Blair
David MacDonald – Truist
Pito Chickering – Deutsche Bank
Jamie Perse – Goldman Sachs
Michael Petusky – Barrington Research
Operator
Good day and thank you for standing by. Welcome to the Option Care Health Second Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded.
I would now like to hand the conference over to your speaker today, Mike Shapiro, Chief Financial Officer. Please go ahead.
Mike Shapiro
Good morning. Please note that today's discussion will include certain forward-looking statements that reflect our current assumptions and expectations, including those related to future financial performance and industry and market conditions. These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from our expectations. We encourage you to review the information in today's press release as well as in our Form 10-K filed with the SEC regarding the specific risks and uncertainties.
We do not undertake any duty to update any forward-looking statements, except as required by law. During the call, we will use non-GAAP financial measures when talking about the company's performance and financial condition. You can find additional information on these non-GAAP measures in this morning's press release posted on the Investor Relations portion of our website.
And with that, I'll turn the call over to John Rademacher, Chief Executive Officer.
John Rademacher
Thanks, Mike, and good morning everyone. The second quarter was a very dynamic period for the Option Care Health team, and we will discuss many of these items in our prepared remarks. First and foremost, I cannot be more grateful for our team or more proud of the execution and dedication that was demonstrated across the organization. Their focus continues to enable us to provide unparalleled patient care and customer service, which translates into strong key performance, metric achievement and financial results in the quarter.
As always, Mike will review the results in greater detail, but I'll cover some of the highlights. The growth profile of the business continues to be strong as we delivered solid results across the board. Revenue growth of 9% was comprised of balanced growth across the acute and chronic portfolio, and due largely to our strong execution and unique procurement benefits in the quarter that Mike will discuss, adjusted EBITDA was $110 million and adjusted EBITDA margin exceeded 10%.